IL129336A0 - Method for preparing compositions for transferring nucleic acids - Google Patents
Method for preparing compositions for transferring nucleic acidsInfo
- Publication number
- IL129336A0 IL129336A0 IL12933697A IL12933697A IL129336A0 IL 129336 A0 IL129336 A0 IL 129336A0 IL 12933697 A IL12933697 A IL 12933697A IL 12933697 A IL12933697 A IL 12933697A IL 129336 A0 IL129336 A0 IL 129336A0
- Authority
- IL
- Israel
- Prior art keywords
- nucleic acids
- preparing compositions
- transferring nucleic
- transferring
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Nanotechnology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9612259A FR2754272B1 (en) | 1996-10-08 | 1996-10-08 | PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR TRANSFERRING NUCLEIC ACIDS |
PCT/FR1997/001747 WO1998015639A1 (en) | 1996-10-08 | 1997-10-03 | Method for preparing compositions for transferring nucleic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
IL129336A0 true IL129336A0 (en) | 2000-02-17 |
Family
ID=9496468
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12933697A IL129336A0 (en) | 1996-10-08 | 1997-10-03 | Method for preparing compositions for transferring nucleic acids |
Country Status (15)
Country | Link |
---|---|
US (1) | US6156338A (en) |
EP (1) | EP0948638A1 (en) |
JP (1) | JP2001501641A (en) |
KR (1) | KR20000048958A (en) |
AU (1) | AU723371B2 (en) |
BR (1) | BR9712210A (en) |
CA (1) | CA2267187A1 (en) |
CZ (1) | CZ119299A3 (en) |
FR (1) | FR2754272B1 (en) |
HU (1) | HUP9904579A3 (en) |
IL (1) | IL129336A0 (en) |
NO (1) | NO991383L (en) |
SK (1) | SK43199A3 (en) |
WO (1) | WO1998015639A1 (en) |
ZA (1) | ZA979031B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2750704B1 (en) | 1996-07-04 | 1998-09-25 | Rhone Poulenc Rorer Sa | PROCESS FOR PRODUCING THERAPEUTIC DNA |
AU2536299A (en) * | 1998-02-17 | 1999-08-30 | University Of Wales College Of Medicine | Method and apparatus for introducing substances into the cell plasma membrane and/or cytosol |
AU7542301A (en) * | 2000-06-09 | 2001-12-17 | Teni Boulikas | Encapsulation of plasmid DNA (lipogenes<sup>TM</sup>) and therapeutic agents with nuclear localization signal/fusogenic peptide conjugates into targeted liposome complexes |
EP1513538A4 (en) * | 2002-06-14 | 2007-08-22 | Mirus Bio Corp | Novel methods for the delivery of polynucleotides to cells |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4873089A (en) * | 1985-07-12 | 1989-10-10 | Cornell Research Foundation Inc., Cornell University | Proteoliposomes as drug carriers |
JPS63277618A (en) * | 1987-03-31 | 1988-11-15 | Noebia:Kk | Production of liposome |
JPH03501732A (en) * | 1987-12-22 | 1991-04-18 | ザ リポソーム カンパニー,インコーポレイテッド | Spontaneous vesiculation method for multilamellar liposomes |
FR2714830B1 (en) * | 1994-01-10 | 1996-03-22 | Rhone Poulenc Rorer Sa | Composition containing nucleic acids, preparation and uses. |
FR2727679B1 (en) * | 1994-12-05 | 1997-01-03 | Rhone Poulenc Rorer Sa | NEW TRANSFECTION AGENTS AND THEIR PHARMACEUTICAL APPLICATIONS |
-
1996
- 1996-10-08 FR FR9612259A patent/FR2754272B1/en not_active Expired - Fee Related
-
1997
- 1997-10-03 EP EP97943929A patent/EP0948638A1/en not_active Withdrawn
- 1997-10-03 WO PCT/FR1997/001747 patent/WO1998015639A1/en not_active Application Discontinuation
- 1997-10-03 JP JP10517234A patent/JP2001501641A/en active Pending
- 1997-10-03 IL IL12933697A patent/IL129336A0/en unknown
- 1997-10-03 HU HU9904579A patent/HUP9904579A3/en unknown
- 1997-10-03 CA CA002267187A patent/CA2267187A1/en not_active Abandoned
- 1997-10-03 US US09/269,515 patent/US6156338A/en not_active Expired - Fee Related
- 1997-10-03 KR KR1019990703006A patent/KR20000048958A/en not_active Application Discontinuation
- 1997-10-03 BR BR9712210-6A patent/BR9712210A/en not_active Application Discontinuation
- 1997-10-03 CZ CZ991192A patent/CZ119299A3/en unknown
- 1997-10-03 SK SK431-99A patent/SK43199A3/en unknown
- 1997-10-03 AU AU45591/97A patent/AU723371B2/en not_active Ceased
- 1997-10-08 ZA ZA9709031A patent/ZA979031B/en unknown
-
1999
- 1999-03-22 NO NO991383A patent/NO991383L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FR2754272A1 (en) | 1998-04-10 |
ZA979031B (en) | 1998-04-23 |
CZ119299A3 (en) | 1999-07-14 |
KR20000048958A (en) | 2000-07-25 |
CA2267187A1 (en) | 1998-04-16 |
SK43199A3 (en) | 2000-04-10 |
NO991383D0 (en) | 1999-03-22 |
AU4559197A (en) | 1998-05-05 |
JP2001501641A (en) | 2001-02-06 |
AU723371B2 (en) | 2000-08-24 |
FR2754272B1 (en) | 1998-11-13 |
US6156338A (en) | 2000-12-05 |
BR9712210A (en) | 1999-08-31 |
HUP9904579A3 (en) | 2001-06-28 |
HUP9904579A2 (en) | 2000-05-28 |
NO991383L (en) | 1999-03-22 |
WO1998015639A1 (en) | 1998-04-16 |
EP0948638A1 (en) | 1999-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL127416A0 (en) | Method for enhancing gene transfer | |
IL129761A0 (en) | Method for preparing cyclopropylamines | |
IL166186A0 (en) | Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids | |
HK1023588A1 (en) | Process for preparing an asphalt composition | |
GB9713283D0 (en) | Method for preparing aminoalkoxysiloxanes | |
HUP0003905A3 (en) | Method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids | |
HUP9904579A3 (en) | Method for preparing compositions for transferring nucleic acids | |
HUP0004619A3 (en) | Method for preparing formylphosphonic acid | |
HUP0003496A3 (en) | Method for preparing oxazaphosphorin-2-amines | |
ZA9810859B (en) | Process for preparing dialkylphosphinic acids. | |
IL134912A0 (en) | Method for preparing 1-phenylpyrrazolin-3-carboxylic acid derivatives | |
EG21405A (en) | Method for preparing phosphorique acid | |
ZA983777B (en) | Method for preparing formylphosphonic acid | |
IL150954A (en) | Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids | |
HK1058030A1 (en) | Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids | |
SI1023279T1 (en) | Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids | |
AU3718997A (en) | Method for preparing alpha-chloroboronic acids from mannitol | |
HUP9903883A3 (en) | Method for preparing trimethylbenzoquinone | |
SI1032557T1 (en) | Method for preparing bromomethyl-biphenyl derivatives |